Short Communication Open Access
Volume 2 | Issue 1 | DOI: https://doi.org/10.33696/Gynaecology.2.012
Neoadjuvant Chemotherapy Followed by Fertility Sparing Surgery in Stage 1B2 Cervical Cancer
JWM Aarts1, PLM Zusterzeel2,*
- 1Department of Obstetrics and Gynecology, Amsterdam University Medical Center, Amsterdam, The Netherlands
- 2Department of Obstetrics and Gynecology, Radboud University Medical Center, Nijmegen, The Netherlands
Corresponding Author
Petra L.M. Zusterzeel, Petra.Zusterzeel@radboudumc.nl
Received Date: April 27, 2021
Accepted Date: July 01, 2021
Aarts JWM, Zusterzeel PLM. Neoadjuvant Chemotherapy Followed by Fertility Sparing Surgery in Stage 1B2 Cervical Cancer. Arch Obstet Gynecol. 2021; 2(1): 16-19.
Copyright: © 2021 Aarts JWM, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Recommended Articles
Sentinel Lymph Node Biopsy after Neoadjuvant Chemotherapy for Breast Cancer
Breast cancer is the second most common cancer worldwide, affecting nearly one in eight women. Accurate cancer staging is essential for determining the patient’s prognosis and for choosing the appropriate treatment. The staging system most often used is the American Joint Committee on Cancer (AJCC) TNM system, where T refers to the size of the tumor, N refers to spread of the primary cancer to nearby lymph nodes, and M refers to the spread of metastasis to distant sites in the body.
Neoadjuvant Chemotherapy Followed by Fertility Sparing Surgery in Stage 1B2 Cervical Cancer
In 2020 we published a series of 18 patients who underwent neoadjuvant chemotherapy (NACT) and vaginal radical trachelectomy (VRT) as a fertility sparing alternative in stage 1B2 cervical cancer.
Late ECG Changes after Cisplatin-Based Chemotherapy in Testicular Cancer Survivors
Introducing cisplatin-based therapy into testicular cancer treatment represents a substantial progress in therapy leading to a longer survival of patients and less adverse effects; currently it represents the standard therapy.
Chemotherapy Promotes Release of Exosomes Which Upregulate Cholesterol Synthesis and Chemoresistance in AML Blasts
Extracellular vesicles (EVs) are emerging as a key mediator of intercellular communication as well as a major mechanism of functional reprogramming of cells in disease. All cells produce EVs, which freely circulate and are found in all body fluids. EVs are heterogenous, consisting of subsets of vesicles with different sizes, distinct origins, and various functions (Figure 1). They mediate a broad variety of biological events ranging from cellular activation, inflammation, blood coagulation, angiogenesis, cellular transport, and others.
Long-term Intraperitoneal Chemotherapy for Malignant Peritoneal Mesothelioma
In the United States malignant peritoneal mesothelioma (MPM) is a rare disease with approximately 300 new cases each year. The malignancy progresses within the peritoneal space throughout its natural history so that a majority of patients die as a result of massive disease within the abdomen and pelvis. Persistence and then progression of mesothelioma occurs despite extensive surgical procedures to eradicate the disease.